RSV vaccine study: do nursing home residents get same protection?
NCT ID NCT06077149
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 24 times
Summary
This study looked at how well new RSV vaccines work in adults over 60 living in long-term care facilities compared to those living at home. Researchers measured antibody levels before and after vaccination in 152 participants. The goal was to see if the immune response is similar between the two groups, which could help protect vulnerable older adults in nursing homes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Rochester Medical Center
Rochester, New York, 14642, United States
Conditions
Explore the condition pages connected to this study.